Autres langues Vaxxinity, Inc.

Actions

VAXX

US92244V1044

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 23/04/2024			Varia. 5j.	Varia. 1 janv.
0,2 ^USD	-25,82 %		-54,52 %	-76,47 %

27/03	Vaxxinity, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
07/03	Vaxxinity annonce des données positives sur l'engagement des cibles dans l'essai clinique de phase 1 pour la maladie de Parkinson lors de la conférence AD/PD ? 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sector Update: Health Care Stocks Advance Premarket Monday	22/04
Sector Update: Health Care	22/04
Vaxxinity Issues Shareholder Letter	20/04
Vaxxinity Issues Shareholder Letter	20/04
Vaxxinity to Voluntarily Delist From Nasdaq; Shares Sink After Hours	19/04
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock	19/04
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting	28/03
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates	27/03
Vaxxinity, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
North American Morning Briefing : Tech in Focus on -2-	25/03
Vaxxinity : UB-312 Target Engagement - ADPD 2024	12/03
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024	07/03
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson?s Disease at AD/PD? 2024	07/03
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published	15/02
Vaxxinity, Inc. Announces the Publication of Data from Multiple Non-Human Primate Studies	15/02
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024	13/02
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024	13/02
Vaxxinity, Inc. to Present Data from UB-312 Program in Parkinson's Disease at International Conference on Alzheimer's and Parkinson's Diseases and Related Neurolog Disorders	13/02
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida	30/01
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida	30/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Vaxxinity, Inc.

Actions

VAXX

US92244V1044

Autres langues

Filtres